Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s): MEDXF

Healthcare

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its... see more

Add To Watchlist

Bullboard (TSX:MDP)

View:

Comment by cleareyeon Nov 17, 2023 8:00am

RE:High volume at support

I allow myself one prediction of support, and this one broke. There is other support at levels nearby but only a fool says "cross this red line",then, "okay well, how about, do not ...more

182

Discussion

Post by cleareyeon Nov 14, 2023 1:42am

High volume at support

The share price hit a high of around 2.20 last July 4th, and then bounced off support at a low of 1.78 for a few days before beginning a journey to over 3.00. Now, we're back at that support of 1 ...more

345

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Post by existaboon Nov 10, 2023 11:28am

TREO

I guess some shareholders don't like hearing more delay...now we have an ugly chart...

142

Post by Paparico1on Nov 09, 2023 6:27pm

We back to

We back to low shorts again. If bids get pulled and no shorts to balance market, be careful. Always respect the market.

143

(0)
•••

Post by PressReleaseon Nov 08, 2023 5:31pm

New Press Release - Medexus Announces Strong Fiscal Q2 2024 Results, Including Quarterly Revenue of US$30.3 Million

Fiscal Q2 2024 revenue reflects a 9.4% increase over fiscal Q2 2023, demonstrating strong revenue growth and continued overall performanceManagement to host conference call at 8:00 AM Eastern time on Thursday, November 9, 2023Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 8...read article.

Comment by zakmirzaon Nov 02, 2023 11:26am

RE:RE:Prediction Alert!

Yup.

106

Discussion

(0)
•••

Post by PressReleaseon Nov 01, 2023 7:01am

New Press Release - Medexus Schedules Second Fiscal Quarter 2024 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 1, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, November 9, 2023 to discuss Medexus's results for its second fiscal quarter ended September 30, 2023...read article.

Comment by lscfaon Oct 19, 2023 8:34am

RE:RE:RE:Ability to pay down 40 mil

“Medexus has drawn down US $18M of its BMO Accordian debt facility which was used to fully repaid its convertible debentures off with cash. MDP also announced that it has compeleted its C$11.5M ...more

157

Discussion

(0)
•••

Post by PressReleaseon Oct 17, 2023 9:16am

New Press Release - Medexus Announces Full Exercise and Closing of Over-Allotment Option in Bought-Deal Public Offering

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 17, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that, in connection with its recently completed bought-deal public offering (Offering) of units (Units), Medexus has issued an additional 508,484...read article.

Comment by lscfaon Oct 16, 2023 5:13pm

RE:RE:Ability to pay down 40 mil

Co must have tapped into $20 million accordion feature of credit facility.

Discussion

Comment by lscfaon Oct 16, 2023 5:07pm

RE:Ability to pay down 40 mil

Co. not telling us the whole story. Cash at June 30 was $15.8 mil US + pp financing of $7.4 mil US => $14.3 mil US shortfall to repay $37.5 mil US debt. No way they did $14.3 mil US cash flow in ...more

118

Discussion

Post by Rockafellow2on Oct 06, 2023 2:49pm

Ability to pay down 40 mil

Is a remarkable achievement if it's all cash . They seem to be able to reduce debt considerably over a one year period so I give them credit due to the high interest rate. I understand from ...more

225

Discussion

Comment by Napcooon Oct 06, 2023 8:02am

RE:Prediction Alert!

Debt reduction?! 40 mln debentures due on October 16, the company issued new debt to replace old debt or issue new shares by diluting, the fundamental did not change, still heavy in debt

119

Discussion

Post by Rockafellow2on Oct 05, 2023 4:20pm

Prediction Alert!

This will shoot up $7 bucks the day they announce debt reduction on Oct 16th ... not before. That's a week this coming Monday ... Get ready to fill your pockets. Imo

195

Discussion

(0)
•••

Post by PressReleaseon Sep 21, 2023 5:01pm